Rebuilding Immunity: EBV‑Targeted T Cells Turn a Hidden Virus into a Treatable Threat
EBV‑specific T‑cell therapy rebuilds the body’s antiviral defenses by training immune cells to recognize and eliminate EBV‑infected cells, offering long‑term control of a once‑dangerous post‑transplant complication. This targeted, cell‑based approach shifts care from short‑term viral suppression to durable immune restoration with fewer side effects than traditional chemotherapy.